| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Payments of employee taxes related to net settlement of equity awards | 0 | 0 |
| Net cash provided by financing activities | 202 | 194 |
| Net increase in cash, cash equivalents and restricted cash | 88 | 98 |
| Cash and cash equivalents at beginning of period | 153 | - |
| Cash and cash equivalents at end of period | 241 | - |
Arcus Biosciences, Inc. (RCUS)
Arcus Biosciences, Inc. (RCUS)